Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to verify the function of p16 hydroxymethylation diagnostic reagents in early diagnosis of oral cancer.


Clinical Trial Description

Background:Oral epithelial dysplasia (OED) is one of the common precancerous lesions among Chinese adults. To investigate the clinical predictive value of p16 hydroxymethylation diagnostic reagents in the early diagnosis of oral cancer, the investigators carried out the prospective multi-center double-blind cohort study.

Methods:265 patients with histologically confirmed mild or moderate OED were included in the present study. After the bisulfite modification and tet assistant bisulfite modification, MethyLight and Methylation-specific PCR (MSP) assays were used to analyze p16 methylation and status in these patients. Building three follow-up queue by p16-methylated, p16-hydroxymethylation and p16-unmethylated. The Statistical analysis used SPSS16.0. All P-values were two-sided. P<0.05 was considered to test for statistical significance difference. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02967120
Study type Observational
Source Beijing Municipal Administration of Hospitals
Contact Zhaojun Liu, PhD
Phone 86-010-88196721
Email liuzhaojun@bjmu.edu.cn
Status Recruiting
Phase N/A
Start date January 2014
Completion date January 2018

See also
  Status Clinical Trial Phase
Completed NCT04153266 - Oral Epithelial Dysplasia Informational Needs Questionnaire
Enrolling by invitation NCT01987934 - Comparison of Morphometric Assessment Using Methyl Green Pyronin and AgNOR Staining of Oral Squamous Cell Carcinoma N/A
Recruiting NCT03418454 - The Oral Microbiome as a Prognostic Tool in Oral Malignant and Premalignant Lesions and in Medication Related Osteonecrosis of the Jaw